Clinical trial

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

NCT02810873

Study summary

ClinicalTrials.gov

Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Positron Emission Mammography Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Positron Emission Tomography Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Fludeoxyglucose F-18 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Copper Cu 64 TP3805 Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-09-01

PhaseNA

Conditions

Breast Carcinomaverified · MONDO: breast carcinoma

Interventions

Positron Emission MammographyDEVICE

Positron Emission TomographyDEVICE

Fludeoxyglucose F-18RADIATION

Copper Cu 64 TP3805DRUG

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson Universitylead sponsor

National Institutes of Health (NIH)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02810873 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.